Working… Menu

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients (HCV004)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01701336
Recruitment Status : Completed
First Posted : October 5, 2012
Last Update Posted : August 29, 2013
European Commission
Information provided by (Responsible Party):
ReiThera Srl

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2012
Actual Study Completion Date : February 2013